Author:
Sessa Ben,Johnson Matthew W.
Abstract
SummaryAfter a 40-year hiatus there is now a revisiting of psychedelic drug therapy
throughout psychiatry, with studies examining the drugs psilocybin,
ketamine, ibogaine and ayahuasca in the treatment of drug dependence.
Limitations to these therapies are both clinical and legal, but the
possibility of improving outcomes for patients with substance dependency
imposes an obligation to research this area.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献